rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
1995-9-21
|
pubmed:abstractText |
To determine whether treatment of endometriosis with a GnRH analogue (GnRH-a; goserelin) combined with continuous estrogen and progestogen hormone replacement therapy (HRT) would prevent the hypoestrogenic effects, including loss of bone density, while maintaining efficacy for treatment of endometriosis.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0015-0282
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
64
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
474-81
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:7641897-Adult,
pubmed-meshheading:7641897-Bone Density,
pubmed-meshheading:7641897-Endometriosis,
pubmed-meshheading:7641897-Estradiol,
pubmed-meshheading:7641897-Estrogen Replacement Therapy,
pubmed-meshheading:7641897-Female,
pubmed-meshheading:7641897-Follicle Stimulating Hormone,
pubmed-meshheading:7641897-Goserelin,
pubmed-meshheading:7641897-Humans,
pubmed-meshheading:7641897-Lipids,
pubmed-meshheading:7641897-Luteinizing Hormone,
pubmed-meshheading:7641897-Medroxyprogesterone Acetate,
pubmed-meshheading:7641897-Premenopause,
pubmed-meshheading:7641897-Prospective Studies
|
pubmed:year |
1995
|
pubmed:articleTitle |
Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial.
|
pubmed:affiliation |
Queen Charlotte's and Chelsea Hospital, London, United Kingdom.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|